Dr. Reddy's Laboratories has launched the first generic version of Bayer/Alcon’s Ciprodex (ciprofloxacin/dexamethasone) 0.3%/0.1% otic suspension in the US, as rival Endo International suffered a “major” setback for its filing from the US Food and Drug Administration.
The Indian firm’s launch, into a market valued at more than $450m for the 12 months to 30 June, came...




